🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 02/03/1989 | 0,0652 USD |
| 29/11/1988 | 0,0588 USD |
| 29/08/1988 | 0,0469 USD |
| 03/06/1988 | 0,0509 USD |
| 29/02/1988 | 0,0509 USD |
| 01/12/1987 | 0,0424 USD |
| 28/08/1987 | 0,0424 USD |
| 02/06/1987 | 0,0292 USD |
| 02/03/1987 | 0,0292 USD |
| 02/12/1986 | 0,0292 USD |
| 02/09/1986 | 0,0292 USD |
| 03/06/1986 | 0,0239 USD |
| 27/02/1986 | 0,0239 USD |
| 03/12/1985 | 0,0239 USD |
| 30/08/1985 | 0,0212 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 23/07/2013 | 45,62 | 46,01 | 45,36 | 45,73 | +0,44% | 1,42% | 9.685.616 |
| 22/07/2013 | 45,66 | 46,04 | 45,37 | 45,53 | -0,15% | 1,46% | 11.861.998 |
| 19/07/2013 | 45,30 | 45,73 | 45,04 | 45,60 | +0,82% | 1,52% | 14.911.678 |
| 18/07/2013 | 45,83 | 45,93 | 45,18 | 45,23 | -1,52% | 1,62% | 18.677.456 |
| 17/07/2013 | 46,07 | 46,54 | 45,93 | 45,93 | -0,21% | 1,33% | 9.964.174 |
| 16/07/2013 | 46,34 | 46,59 | 45,83 | 46,02 | -0,60% | 1,65% | 16.006.733 |
| 15/07/2013 | 46,29 | 46,65 | 46,05 | 46,30 | -0,04% | 1,30% | 10.117.811 |
| 12/07/2013 | 46,18 | 46,43 | 45,98 | 46,32 | +0,48% | 0,97% | 9.280.564 |
| 11/07/2013 | 46,21 | 46,28 | 45,93 | 46,10 | +0,73% | 0,76% | 11.991.216 |
| 10/07/2013 | 45,44 | 45,97 | 45,41 | 45,76 | +0,71% | 1,24% | 8.154.174 |
| 09/07/2013 | 45,53 | 45,80 | 45,43 | 45,44 | +0,44% | 0,82% | 10.811.902 |
| 08/07/2013 | 45,20 | 45,45 | 45,08 | 45,24 | +0,53% | 0,82% | 11.504.315 |
| 05/07/2013 | 44,78 | 45,13 | 44,48 | 45,00 | +1,31% | 1,47% | 8.491.944 |
| 03/07/2013 | 44,35 | 44,59 | 44,05 | 44,42 | +0,00% | 1,23% | 7.203.952 |
| 02/07/2013 | 43,98 | 44,59 | 43,92 | 44,42 | +0,50% | 1,52% | 11.859.063 |
| 01/07/2013 | 44,14 | 44,70 | 44,10 | 44,20 | -0,28% | 1,36% | 13.741.586 |
| 28/06/2013 | 45,29 | 45,31 | 44,32 | 44,32 | -1,76% | 2,17% | 17.124.110 |
| 27/06/2013 | 44,88 | 45,19 | 44,72 | 45,11 | +1,26% | 1,04% | 12.198.510 |
| 26/06/2013 | 44,47 | 44,76 | 44,16 | 44,55 | +0,99% | 1,35% | 11.984.823 |
| 25/06/2013 | 44,40 | 44,54 | 43,97 | 44,11 | -0,39% | 1,29% | 12.600.104 |
| 24/06/2013 | 44,34 | 44,71 | 43,95 | 44,28 | -1,26% | 1,72% | 18.948.574 |
| 21/06/2013 | 44,72 | 45,42 | 44,53 | 44,85 | +1,49% | 1,98% | 25.453.614 |
| 20/06/2013 | 45,25 | 45,25 | 44,09 | 44,19 | -2,67% | 2,55% | 18.680.495 |
| 19/06/2013 | 45,52 | 45,96 | 45,28 | 45,40 | -0,36% | 1,51% | 18.857.922 |
| 18/06/2013 | 45,69 | 45,85 | 45,48 | 45,56 | -0,10% | 0,81% | 12.384.006 |
| 17/06/2013 | 46,12 | 46,33 | 45,38 | 45,61 | -0,31% | 2,05% | 13.084.490 |
| 14/06/2013 | 45,58 | 46,31 | 45,32 | 45,75 | +0,10% | 2,16% | 14.286.650 |
| 13/06/2013 | 44,60 | 45,74 | 44,36 | 45,71 | +1,38% | 3,10% | 15.482.314 |
| 12/06/2013 | 45,70 | 45,90 | 45,07 | 45,09 | -0,65% | 1,82% | 17.662.887 |
| 11/06/2013 | 45,87 | 45,99 | 45,37 | 45,38 | -1,86% | 1,35% | 56.749.305 |